HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: News
Latest in the world of healthcare and pharma, brought to you all at one place
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
Adalimumab is a medicine that belongs to the class of biologic DMARDs (disease-modifying antirheumatic medications). Humira is a common brand name used in marketing.
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
Semaglutide Semaglutide is a drug developed by Novo Nordisk in 2012, used to treat type 2 diabetes and obesity and is marketed under the brand names Ozempic, Wegovy, and Rybelsus. It is a member of the pharmacological class known as GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists). The hormone GLP-1, which aids in controlling blood…
-
FDA approved Leqembi to have $12.9 billion sales
Leqembi (lecanemab), a recently approved medicine from Biogen/Eisai for the treatment of Alzheimer’s disease, was given FDA approval in January 2023
-
Assistive Technology Market; a $82B Growth Story
Assistive technology for the elderly refers to devices, tools, and systems designed to support older adults in their daily activities, enhance their independence, and improve their overall quality of life. With the use of assistive technology, people with disabilities can engage in civic activities, the job market, and lead a productive, independent existence. The use…
-
5+ Impactful Uses of Enterprise Resource Planning (ERP) System in Healthcare
ERP for hospital management systems plays a vital role in reducing clinical errors and enhancing operations through increased efficiency and coordinated data analyses. Artificial intelligence (AI) has made a significant impact on the healthcare industry, changing how we identify, treat, and monitor patients.
-
Neuralink; An attempt to transform into Cyborgs ?
Neuralink, a jump in advancement
-
CAR-T CELL to witness CAGR of 11.37% growth
CAR-T CELL to witness CAGR of 11.37% growth
-
GSK acquires Tesaro for $5.1 Billion – The market is buzzing
GSK acquires Tesaro for $5.1 Billion – The market is buzzing
-
FIRST DEATH DUE TO NIPAH VIRUS IN KERALA
A 12 year old boy, Muhammad Hashim dies of Nipah virus in Kozhikode on Sunday morning. The Central Government has confirmed the case and a team of National Centre for Disease Control was rushed to kerala for technical support. Kerala’s health minister, Veena George has also went to assess the situation. A team including health…
-
INDIA’S FIRST CASE OF H5N1 AVIAN INFLUENZA IN HUMAN
First case of human infection of influenza A(H5N1) virus in India has been reported on July 21, 2021. The patient was a 18 year old male from Harayana. Symptoms observed(in June) were fever, cough, difficulty in breathing and other upper respiratory symptoms after he was given an immunosuppressive treatment for an underlying illness. Patient’s condition further deteriorated leading to acute respitatory distress syndrome(ARDS).…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila